Business
Regeneron taps Telix platform for solid-tumor radiopharma programs
The companies will co-develop radiopharmaceutical therapies and radiodiagnostics across multiple solid tumor targets.
Section
All News
Every story we've published, newest first. 318 articles.
Practice
ACR fund backs screening for patients outside cancer guidelines
The Cancer Doesn’t Care Fund will support pilot programs, community partnerships, technology development, and policy research for earlier cancer detection.
Practice
ARRS Gold Medal goes to Jonathan Kruskal and Douglas Katz
Jonathan B. Kruskal, MB, ChB, PhD, and Douglas S. Katz, MD, received the society’s highest honor during the opening ceremony of the 2026 ARRS Annual Meeting in Pittsburgh.
Clinical
Ultrasonic biopsy needle increases tissue yield in pilot study
Researchers found that ultrasound-enhanced fine-needle aspiration biopsy produced larger tissue samples than conventional fine-needle and core-needle biopsy in benign parotid gland tumors without reducing sample quality.
Practice
ClinicalTrials.gov reporting gap draws FDA compliance push
The agency sent messages tied to more than 3,000 registered trials that appear to lack required results information on ClinicalTrials.gov.
Clinical
Sirtex reports 100% local tumor control in HCC trial
The DOORwaY90 study reported a 90% complete response rate and 99% best overall response rate for SIR-Spheres Y-90 resin microspheres.
Practice
Heartflow sues Cleerly over cardiac AI patents
The lawsuit alleges that Cleerly’s Ischemia, Plaque Analysis, and Compare products infringe 6 Heartflow patents.
AI & Imaging
SimonMed, Matricis.ai launch endometriosis MRI AI pilot
The pilot will assess EndomAI, an MRI-based tool designed to help radiologists detect, map, and characterize endometriosis.
Practice
California court dismisses Anthem NSA IDR challenge
The court dismissed Anthem Blue Cross claims against HaloMD and physician groups over No Surprises Act independent dispute resolution awards.
Business
Conditional DOE loan could advance domestic Mo-99 supply
The conditional commitment would support completion of Chrysalis, a Janesville, WI, facility designed to establish domestic commercial production of molybdenum-99.